Drugs / Fibrin glue
Fibrin glue
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT02153593 | Mar 2013 → Mar 2015 | bone neoplasm | Sant Pau Research Institute | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT02150720 | Feb 2013 → Apr 2015 | — | Sant Pau Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT01306370 | Jun 2010 → Oct 2011 | arthropathy | Sant Pau Research Institute | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03920306 | Apr 2019 → Sep 2024 | gastrocutaneous syndrome | University of British Columbia | Completed | No outcome recorded |
| Comparator or background therapy8 trials | ||||||
| Phase 1 | NCT05553132 Background | Aug 2023 → Dec 2026 expected | cartilage development disorder | Daniel B. F. Saris | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06840561 Background | Nov 2021 → Dec 2024 | esophageal cancer | Sun Yat-sen University Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT03449082 Background | Mar 2018 → Jul 2019 | epicondylitis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02298023 Comparator | Sep 2014 → Jul 2016 | rotator cuff syndrome | Seoul National University Hospital | Completed | Missed primary |
| Phase 3 | NCT04612465 Comparator | Jan 2020 → Apr 2025 overdue | intestinal fistula | Anterogen Co., Ltd. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT01803347 Comparator | Feb 2013 → Oct 2017 | anal fistula | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Completed | No outcome recorded |
| Phase 3 | NCT01631448 Comparator | May 2010 → Jan 2014 | lymphocele, urinary tract obstruction, vascular insufficiency disorder | Alejandro Gonzalez-Ojeda | Completed | No outcome recorded |
| Phase 4 | NCT01306851 Comparator | Jun 2007 → Mar 2013 | intestinal perforation | Hospital General Universitario Gregorio Marañon | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibrin glue | “2. A topical adhesive of either 2-Octylcyanoacrylate glue (Dermabond), or Fibrin glue, or Histoacryl glue (Tissue Seal), will be applied over the fistula's aperture.” NCT03920306 ↗ |
| Known as | Fibrin adhesive | “•Active Comparator: Fibrin glue Intervention: Drug: Fibrin adhesive” NCT01803347 ↗ |
| Known as | Porcine fibrin sealant kit | “The operator checked the wound to make sure there was no bleeding or perforation after the TA injection, then sprayed 5-10ml fibrin glue (Porcine fibrin sealant kit, China) on...” NCT06840561 ↗ |
| Modality | Protein / enzyme biologic | “It is homologous fibrin glue from a single blood donor.” NCT01306370 ↗ |
| Route | Topical | “Topical administration, before to close the surgical wound.” NCT01306370 ↗ |